NYSE: DOCSDoximity Inc Stock
$24.82-0.37 (-1.47%)
Updated Apr 18, 2024
DOCS Price
$24.82
Fair Value Price
N/A
Market Cap
$4.63B
52 Week Low
$19.71
52 Week High
$37.06
P/E
34.47x
P/B
5.36x
P/S
11.16x
PEG
1.03x
Dividend Yield
N/A
Revenue
$468.33M
Earnings
$137.63M
Gross Margin
88.9%
Operating Margin
37.15%
Profit Margin
29.4%
Debt to Equity
0.16
Operating Cash Flow
$167M
Beta
1.68
Next Earnings
May 16, 2024
Ex-Dividend
N/A
Next Dividend
N/A
DOCS Overview
Doximity. Inc. is an online networking service enabling medical professionals to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. Formerly known as 3MD Communications, Inc., the company was launched in 2010 and is headquartered in San Francisco, CA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DOCS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DOCS ($24.82) is trading above its intrinsic value of $12.37, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DOCS is good value based on its earnings relative to its share price (34.47x), compared to the US market average (41.33x)
P/E vs Market Valuation
DOCS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more DOCS due diligence checks available for Premium users.
Be the first to know about important DOCS news, forecast changes, insider trades & much more!
DOCS News
Valuation
DOCS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
34.47x
Industry
74.25x
Market
41.33x
DOCS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DOCS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
DOCS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.36x
Industry
3.36x
DOCS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DOCS price to earnings growth (PEG)
For valuing profitable companies with growth potential
DOCS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
DOCS's financial health
Profit margin
Revenue
$135.3M
Net Income
$48.0M
Profit Margin
35.4%
DOCS's Earnings (EBIT) of $173.97M... subscribe to Premium to read more.
Interest Coverage Financials
DOCS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.0B
Liabilities
$136.0M
Debt to equity
0.16
DOCS's short-term assets ($840.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DOCS's short-term assets ($840.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DOCS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$50.1M
Investing
$40.1M
Financing
-$75.5M
DOCS's operating cash flow ($166.79M)... subscribe to Premium to read more.
Debt Coverage Financials
DOCS vs Health Information Service Stocks
Doximity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.